Minardo John

CIK: 0001875067

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRWD

IRONWOOD PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

IRWD
IRONWOOD PHARMACEUTICALS INC
Mar 10, 2026
Award(A)
Direct
136.6K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 24, 2026
Sale(S)
Direct
19.1K shares at avg. $3.66$70K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 23, 2026
Sale(S)
Direct
17.4K shares at avg. $3.81$66K
IRWD
IRONWOOD PHARMACEUTICALS INC
Aug 11, 2025
Sale(S)
Direct
7.8K shares at avg. $0.84$7K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 10, 2025
Sale(S)
Direct
38.9K shares at avg. $1.76$69K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 10, 2025
Award(A)
Direct
122.2K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Jan 17, 2025
Award(A)
Direct
40.2K shares-

		Type	Shares	Price		Ownership
Mar 10, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	136,612	-	$0	Direct
Feb 24, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	19,053	$3.66	$69,734	Direct
Feb 23, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	17,439	$3.81	$66,443	Direct
Aug 11, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	7,754	$0.84	$6,513	Direct
Feb 10, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	38,938	$1.76	$68,531	Direct
Feb 10, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	122,222	-	-	Direct
Jan 17, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	40,187	-	$0	Direct

1-7 of 7 transactions

About John Minardo

John Minardo (SEC CIK 0001875067) files insider reports with the SEC as Chief Legal Officer of IRONWOOD PHARMACEUTICALS INC (IRWD).

Signal8 holds 5 ownership filings by John Minardo, all Form 4s, filed between Jan 22, 2025 and Mar 12, 2026. Those filings report 7 transactions, from Jan 17, 2025 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on John Minardo's filings is in BOSTON, MA.

Recent filings by John Minardo

Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).
Aug 11, 2025: Open-market sale of IRWD shares (Form 4, code S).
Feb 10, 2025: Open-market sale of IRWD shares (Form 4, code S).

Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)

DENNER ALEXANDER J, Director
Silber Jeffrey, SVP, CMO, Head-Res&Drug
Silver Ronald, PFO & PAO
Shepard Jay, Director
Kessler Marla L, Director
Currie Mark G, Director

How to read Form 4 transaction codes